JP6219300B2 - 膵臓癌を診断するための装置及び方法 - Google Patents

膵臓癌を診断するための装置及び方法 Download PDF

Info

Publication number
JP6219300B2
JP6219300B2 JP2014543889A JP2014543889A JP6219300B2 JP 6219300 B2 JP6219300 B2 JP 6219300B2 JP 2014543889 A JP2014543889 A JP 2014543889A JP 2014543889 A JP2014543889 A JP 2014543889A JP 6219300 B2 JP6219300 B2 JP 6219300B2
Authority
JP
Japan
Prior art keywords
biomarker
pancreatic cancer
subject
sample
ceramide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014543889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015502541A5 (https=
JP2015502541A (ja
Inventor
レスツカ，レギーナ
カムラゲ，ベアテ
カルトホフ，ホルガー
シュニーヴィント，ボドー
マイヤーレ，ユリア
レルヒ，マルクス
ピラースキー，クリスティアン
グリュッツマン，ロバート
Original Assignee
メタノミクス ヘルス ゲーエムベーハー
メタノミクス ヘルス ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メタノミクス ヘルス ゲーエムベーハー, メタノミクス ヘルス ゲーエムベーハー filed Critical メタノミクス ヘルス ゲーエムベーハー
Publication of JP2015502541A publication Critical patent/JP2015502541A/ja
Publication of JP2015502541A5 publication Critical patent/JP2015502541A5/ja
Application granted granted Critical
Publication of JP6219300B2 publication Critical patent/JP6219300B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Gastroenterology & Hepatology (AREA)
JP2014543889A 2011-11-30 2012-11-29 膵臓癌を診断するための装置及び方法 Expired - Fee Related JP6219300B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161564891P 2011-11-30 2011-11-30
EP11191365.3 2011-11-30
EP11191365 2011-11-30
US61/564,891 2011-11-30
PCT/EP2012/073965 WO2013079594A1 (en) 2011-11-30 2012-11-29 Device and methods to diagnose pancreatic cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017185522A Division JP2018049016A (ja) 2011-11-30 2017-09-27 膵臓癌を診断するための装置及び方法

Publications (3)

Publication Number Publication Date
JP2015502541A JP2015502541A (ja) 2015-01-22
JP2015502541A5 JP2015502541A5 (https=) 2016-01-28
JP6219300B2 true JP6219300B2 (ja) 2017-10-25

Family

ID=48534696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014543889A Expired - Fee Related JP6219300B2 (ja) 2011-11-30 2012-11-29 膵臓癌を診断するための装置及び方法
JP2017185522A Ceased JP2018049016A (ja) 2011-11-30 2017-09-27 膵臓癌を診断するための装置及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017185522A Ceased JP2018049016A (ja) 2011-11-30 2017-09-27 膵臓癌を診断するための装置及び方法

Country Status (6)

Country Link
US (1) US20140323352A1 (https=)
EP (2) EP2786152B1 (https=)
JP (2) JP6219300B2 (https=)
AU (2) AU2012343843B2 (https=)
CA (1) CA2857401A1 (https=)
WO (1) WO2013079594A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084290A1 (ja) 2012-11-27 2014-06-05 味の素株式会社 膵臓癌の評価方法、膵臓癌評価装置、膵臓癌評価方法、膵臓癌評価プログラム、膵臓癌評価システムおよび情報通信端末装置
AU2014368412A1 (en) 2013-12-20 2016-07-07 Metanomics Health Gmbh Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel
EP3146334B1 (en) * 2014-05-23 2019-08-14 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods for determining whether a patient will achieve a response after radiation therapy
JP2017525970A (ja) * 2014-09-01 2017-09-07 メタノミクス ゲーエムベーハー 被験体において心不全を診断するための手段及び方法
EP3314264A1 (en) 2015-06-25 2018-05-02 Metanomics Health GmbH Means and methods for diagnosing pancreatic cancer in a subject based on a biomarker panel
US20180238914A1 (en) * 2015-08-19 2018-08-23 Metanomics Gmbh Means and methods for diagnosing cardiac disease in a subject
JPWO2018066620A1 (ja) * 2016-10-04 2019-07-18 味の素株式会社 膵臓癌の評価方法、評価装置、評価プログラム、評価システム、及び端末装置
KR102549063B1 (ko) * 2016-12-15 2023-06-28 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 췌관 선암종의 검출 및 치료를 위한 방법
EP3502699A1 (en) 2017-12-20 2019-06-26 Metanomics Health GmbH Methods for diagnosing pancreatic cancer
EP3806719B1 (en) * 2018-06-14 2025-08-20 Metabolomycs, Inc. Metabolomic signatures for diagnosing and prognosing ovarian cancer
KR102070916B1 (ko) * 2018-08-31 2020-01-29 연세대학교 산학협력단 췌장암 환자의 예후를 예측하기 위한 바이오마커 및 이의 용도
KR102239206B1 (ko) * 2019-03-06 2021-04-12 연세대학교 산학협력단 절제술 효과 평가 장치 및 시스템
ES2799973A1 (es) * 2019-06-19 2020-12-22 Univ Granada Panel de metabolitos como biomarcadores para el diagnostico de cancer de pancreas
WO2022140380A1 (en) * 2020-12-21 2022-06-30 Pancreomics Llc Metabolomic signatures for predicting, diagnosing, and prognosing chronic pancreatitis
CN113655142B (zh) * 2021-08-09 2023-11-10 大连医科大学附属第一医院 一种基于磷脂酰丝氨酸和磷脂酰乙醇胺的早期预警重症急性胰腺炎的模型与应用
CN114371239B (zh) * 2022-03-22 2022-07-15 长沙都正医学检验有限责任公司 用于测定氧化三甲胺的试剂盒及其制备方法和应用
TWI859033B (zh) 2023-12-18 2024-10-11 安益藥業股份有限公司 一種診斷犬科動物胰臟炎的方法與試劑組與一種使用醯基肉鹼作為診斷犬科動物胰臟炎之用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
JPH02128697A (ja) * 1988-11-09 1990-05-17 Hoechst Japan Ltd 抗フコシルセラミドモノクローナル抗体
US6083929A (en) * 1991-05-06 2000-07-04 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
JP2005526962A (ja) 2002-02-28 2005-09-08 メタノミクス ゲーエムベーハー ウント ツェーオー．カーゲーアーアー 物質の混合物を分析する質量分析方法
AU2003271173A1 (en) * 2002-10-11 2004-05-04 Chugai Seiyaku Kabushiki Kaisha Cell growth regulator
SG10201405975VA (en) * 2009-10-01 2014-11-27 Phenomenome Discoveries Inc Serum-based biomarkers of pancreatic cancer and uses thereof for diseasedetection and diagnosis
EP3355057A3 (en) * 2010-06-01 2018-12-12 Metanomics Health GmbH Means and methods for diagnosing pancreatic cancer in a subject
ES2638522T3 (es) * 2010-06-23 2017-10-23 University Of Louisville Research Foundation, Inc. Procedimientos para detectar cáncer
JP2013540995A (ja) * 2010-08-18 2013-11-07 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 疾患に対する循環バイオマーカー
CN105572276B (zh) * 2014-11-07 2018-12-18 上海市第六人民医院 胰腺癌诊断标记物组合、应用及其测定方法

Also Published As

Publication number Publication date
AU2012343843B2 (en) 2018-03-08
EP2786152B1 (en) 2019-01-02
JP2015502541A (ja) 2015-01-22
JP2018049016A (ja) 2018-03-29
EP3486657A2 (en) 2019-05-22
AU2018203939A1 (en) 2018-06-21
WO2013079594A1 (en) 2013-06-06
EP3486657A3 (en) 2019-06-12
AU2012343843A1 (en) 2014-06-12
EP2786152A1 (en) 2014-10-08
US20140323352A1 (en) 2014-10-30
CA2857401A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
JP6286475B2 (ja) 対象において膵臓がんを診断する手段及び方法
JP6219300B2 (ja) 膵臓癌を診断するための装置及び方法
US10168333B2 (en) Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel
CA2799032A1 (en) Methods to diagnose liver diseases
AU2011209431A1 (en) Means and methods for diagnosing heart failure in a subject
AU2010326737A1 (en) Means and methods for diagnosing multiple sclerosis
JP6421118B2 (ja) 前立腺摘出術後の前立腺癌の再発の診断のための手段および方法
AU2012264688A2 (en) Methods for diagnosing multiple sclerosis
ES2717458T3 (es) Dispositivo y procedimientos para diagnosticar cáncer de páncreas

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151130

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170814

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170829

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170927

R150 Certificate of patent or registration of utility model

Ref document number: 6219300

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees